A material will not have to be stated to be a managed material through the DEA to generally be addressed to be a Program I substance for prison prosecution. A managed material analogue (as an example, a "designer drug") is often a material which can be structurally or pharmacologically similar to a Timetable I or Schedule II compound, exclusively u